Pancreatic Cancer Market Size Share Growth Opportunities and Forecast 2023-2030

Global Pancreatic Cancer Market to Reach US$ 5.7 Billion by 2030: DataM Intelligence Analysis

The global pancreatic cancer market, valued at US$ 2.5 billion in 2022, is poised for substantial growth, projected to reach US$ 5.7 billion by 2030, according to the latest analysis by DataM Intelligence. The market is expected to exhibit a Compound Annual Growth Rate (CAGR) of 11.1% during the forecast period of 2023-2030.

Market Overview:

Pancreatic cancer, a significant health concern worldwide, has witnessed an escalating prevalence, leading to increased market traction. The market encompasses a range of treatment options, with chemotherapy playing a pivotal role in eradicating cancer cells post-surgery or as primary treatment for advanced cases.

Download Sample: https://www.datamintelligence.com/download-sample/pancreatic-cancer-market

Key Metrics:

CAGR: 11.1%
Forecast Period: 2023-2030
Size Available for Years: 2021-2030

Market Scope:

The market is segmented based on treatment type and end-user, covering regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. Notably, the Asia-Pacific region emerges as the fastest-growing, while North America holds the largest market share.

Market Dynamics:

The rise in pancreatic cancer cases globally, influenced by factors such as obesity, passive smoking, and chronic inflammation, is a driving force behind market growth. DataM Intelligence highlights the importance of understanding the prevalence patterns before implementing policies and interventions.

FDA approvals for innovative products, such as MT-601, a multi-tumor-associated antigen (MultiTAA)-specific T cell product, are contributing to market expansion. However, the market faces challenges due to side effects associated with therapeutics, impacting patient well-being.

Segment Analysis:

The chemotherapy segment dominates the market, accounting for approximately 37.6% in 2022. Popular medications include Gemcitabine, 5-fluorouracil (5-FU), Oxaliplatin, and others used for both adjuvant and neoadjuvant chemotherapy.

Geographical Penetration:

North America holds a dominant position with an estimated 39.3% market share, driven by rising pancreatic cancer cases and advancements in treatment and diagnosis.

To know more Insights on the Report: https://www.datamintelligence.com/research-report/pancreatic-cancer-market

Competitive Landscape:

Major global players in the market include Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Amgen Inc., Viatris Inc., Boston Scientific Corporation, Clovis Oncology, and GlaxoSmithKline.

By Treatment Type:

Targeted Therapies
Chemotherapy
Surgery
Other Treatments
By End-user:

Hospitals
Specialty Clinics
Home Care
Others
By Region:

North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
South America (Brazil, Argentina, Rest of South America)
Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific)
Middle East and Africa

Related Reports:

Exocrine Pancreatic Insufficiency Market: https://www.datamintelligence.com/research-report/exocrine-pancreatic-insufficiency-market

Locally Advanced Pancreatic Cancer Market: https://www.datamintelligence.com/research-report/locally-advanced-pancreatic-cancer-market

Artificial Pancreas Market: https://www.datamintelligence.com/research-report/artificial-pancreas-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.